BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 3337899)

  • 1. Natural history of idiopathic refractory sideroblastic anemia.
    Cazzola M; Barosi G; Gobbi PG; Invernizzi R; Riccardi A; Ascari E
    Blood; 1988 Feb; 71(2):305-12. PubMed ID: 3337899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Refractory cytopenia with multilineage dysplasia: further characterization of an 'unclassifiable' myelodysplastic syndrome.
    Rosati S; Mick R; Xu F; Stonys E; Le Beau MM; Larson R; Vardiman JW
    Leukemia; 1996 Jan; 10(1):20-6. PubMed ID: 8558932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the erythropoiesis in myelodysplasia by means of ferrokinetic studies, in vitro erythroid colony formation and soluble transferrin receptor.
    Brada SJ; de Wolf JT; Hendriks D; Louwes H; van den Berg E; Vellenga E
    Leukemia; 1998 Mar; 12(3):340-5. PubMed ID: 9529128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Idiopathic refractory sideroblastic anemia: clinical and laboratory investigation of 17 patients and review of the literature.
    Kushner JP; Lee GR; Wintrobe MM; Cartwright GE
    Medicine (Baltimore); 1971 May; 50(3):139-59. PubMed ID: 5286053
    [No Abstract]   [Full Text] [Related]  

  • 5. [Acquired idiopathic sideroblastic anemia (author's transl)].
    Sigaux F; Richard MF; Imbert M; Sultan C
    Pathol Biol (Paris); 1979 Sep; 27(7):421-32. PubMed ID: 388322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Acquired idiopathic sideroblastic anemia. Apropos of 39 cases].
    Fenaux P; Estienne MH; Laï JL; Beuscart R; Dupriez B; Jouet JP; Bauters F
    Rev Med Interne; 1989; 10(4):323-9. PubMed ID: 2799116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis and treatment of sideroblastic anemias: from defective heme synthesis to abnormal RNA splicing.
    Cazzola M; Malcovati L
    Hematology Am Soc Hematol Educ Program; 2015; 2015():19-25. PubMed ID: 26637696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The morphofunctional characteristics of the bone marrow erythroid cells in some forms of the myelodysplastic syndrome].
    Sarycheva TG; Tsvetaeva NV; Kozinets GI
    Ter Arkh; 1993; 65(7):52-4. PubMed ID: 8211781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Refractory myelodysplastic anaemias with hypocellular bone marrow.
    Yoshida Y; Oguma S; Uchino H; Maekawa T
    J Clin Pathol; 1988 Jul; 41(7):763-7. PubMed ID: 3410972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physician Education: Myelodysplastic Syndrome.
    Yoshida Y
    Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum ferritin in refractory anemias.
    Solomon LR; Hillman RS; Finch CA
    Acta Haematol; 1981; 66(1):1-5. PubMed ID: 6794292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Idiopathic refractory sideroblastic anemia: incidence and risk factors for leukemic transformation.
    Cheng DS; Kushner JP; Wintrobe MM
    Cancer; 1979 Aug; 44(2):724-31. PubMed ID: 383260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cytogenetic and hematologic follow-up studies in idiopathic refractory sideroblastic anemia (IRSA) (author's transl)].
    Mende S; Weissenfels I; Pribilla W
    Blut; 1980 Nov; 41(5):367-76. PubMed ID: 7437531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Ring sideroblasts].
    Brattås MKL; Reikvam H
    Tidsskr Nor Laegeforen; 2017 Nov; 137(21):. PubMed ID: 29135187
    [No Abstract]   [Full Text] [Related]  

  • 15. [Acquired idiopathic sideroblastic anemia (author's transl)].
    Sigaux F; Ricard MF; Imbert M; Sultan C
    Sem Hop; 1980 Mar 18-25; 56(11-12):583-94. PubMed ID: 6245466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of clonal chromosomal abnormalities in patients with primary myelodysplastic syndromes.
    Gyger M; Infante-Rivard C; D'Angelo G; Forest L; Lussier P
    Am J Hematol; 1988 May; 28(1):13-20. PubMed ID: 3369432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term disappearance of previous chromosomal abnormalities in myelodysplastic syndromes treated with low dose cytosine arabinoside and granulocyte/macrophage-colony stimulating factor.
    Sastre JL; Ulibarrena C; Bustillo M; Suárez-Gago M; García-Torremocha MS; Vázquez MO
    Haematologica; 1998 Aug; 83(8):763-5. PubMed ID: 9793271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiapoptotic role of growth factors in the myelodysplastic syndromes: concordance between in vitro and in vivo observations.
    Tehranchi R; Fadeel B; Schmidt-Mende J; Forsblom AM; Emanuelsson E; Jadersten M; Christensson B; Hast R; Howe RB; Samuelsson J; Zhivotovsky B; Hellström-Lindberg E
    Clin Cancer Res; 2005 Sep; 11(17):6291-9. PubMed ID: 16144933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does rapidly progressive iron overload in a young girl with sideroblastic anemia also signify the presence of hereditary hemochromatosis?
    Scimeca PG; Weinblatt ME; Kahn E; Kochen JA
    Pediatr Hematol Oncol; 1994; 11(1):99-104. PubMed ID: 8155505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathophysiological classification of acquired bone marrow failure based on quantitative assessment of erythroid function.
    Cazzola M; Bergamaschi G; Huebers HA; Finch CA
    Eur J Haematol; 1987 May; 38(5):426-32. PubMed ID: 3653364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.